Scenario.press - libera espressione Scenario.press - libera espressione
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Marketplace
  • Financement
  • Offres
  • Emplois
  • Courses
  • Film
  • Développeurs
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • akshayg Ajouter une nouvelle offre d'emploi Networking
    2025-07-31 13:59:39 -
    Cancer Immunotherapy Market Anticipating Astonishing Growth in Demand During Forecast With Top Leading Players by Fact MR
    The global cancer immunotherapy market is set to garner US$ 159.2 billion in revenue in 2024, according to Fact.MR, a market research and intelligence provider. Worldwide demand for cancer immunotherapies is projected to increase at a CAGR of 10% and reach a market value of US$ 412.8 billion by 2034.This unprecedented growth presents a unique opportunity for manufacturers and market payers to...
    0 Commentaires 0 Parts 160 Vue
    Connectez-vous pour aimer, partager et commenter!
  • leighdiaz6004 Ajouter une nouvelle offre d'emploi Autre
    2025-01-30 10:00:13 -
    Global Cancer Immunotherapy Market Size, Share, Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2032
    The global Cancer Immunotherapy Market is expected to reach USD 280.17 Biliion by the end of 2032, with a valuation of USD 110.42 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 10.9%. The study examines the factors driving and limiting the global Cancer Immunotherapy Market's...
    0 Commentaires 0 Parts 2KB Vue
    Connectez-vous pour aimer, partager et commenter!
© 2025 Scenario.press - libera espressione French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Confidentialité Business Model Dons Contactez nous Annuaire